secwatch.observer — SEC 8-K summary
======================================

Issuer:     P3 Health Partners Inc. (PIII)
CIK:        0001832511
Form:       8-K
Filed at:   2023-01-11T23:59:59+00:00
Accession:  0001104659-23-003071
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

P3 Health reaffirms 2022 guidance, sees 2023 revenue $1.2B-$1.25B, narrower EBITDA loss
--------------------------------------------------------------------------------

- Reaffirmed FY2022 revenue $1.025B-$1.075B (61-69% YoY growth); at-risk MA membership >100k.
- FY2023 guidance: revenue $1.20B-$1.25B, membership 115k-120k, Adj. EBITDA loss $40M-$60M.
- Company anticipates achieving positive Adj. EBITDA in 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1832511/000110465923003071/0001104659-23-003071-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1832511/000110465923003071/tm233132d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-003071

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer